In a statement Moderna Inc said, a booster dose of its COVID-19 vaccine appears to protect against the fast-spreading Omicron variant of COVID-19 in laboratory tests; its current version of the vaccine will continue to be its “first line of defense… Read More ›
clinical trials
Fujifilm signs manufacturing contract with VLP Therapeutics for COVID-19 vaccine candidate
On Thursday, in a statement Japan’s Fujifilm Holdings Corp said, it has signed a manufacturing contract with U.S.-based VLP Therapeutics for manufacturing a COVID-19 vaccine. In a statement both companies said, “Fujifilm will use its manufacturing facilities and infrastructure to… Read More ›
Beijing grants first COVID-19 vaccine patent to CanSino Biologics Inc
In a significant development, Chinese vaccine specialist CanSino Biologics Inc has been approved by Beijing to produce its COVID-19 vaccine candidate Ad5-nCOV, said a report from the state media citing documents from the China’s intellectual property regulator. This is the… Read More ›
Roche Holding AG acquires Foundation Medicine for $2.4 billion
The strategic move will enable Roche Holding AG to add Foundation Medicine’s portfolio of drugs to its basket of cancer treatments. FMI’s molecular insights will also enable Roche to create and develop new cancer treatments. On Tuesday, Swiss drugmaker Roche… Read More ›